Previous close | 42.19 |
Open | 42.21 |
Bid | 0.00 x 1800 |
Ask | 0.00 x 2200 |
Day's range | 42.14 - 42.35 |
52-week range | 33.33 - 43.84 |
Volume | |
Avg. volume | 3,593,916 |
Market cap | 85.513B |
Beta (5Y monthly) | 0.26 |
PE ratio (TTM) | 13.82 |
EPS (TTM) | 3.05 |
Earnings date | N/A |
Forward dividend & yield | 1.47 (3.48%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | 44.10 |
(Bloomberg) -- Pfizer Inc. has sold over £3 billion ($3.8 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake. Most Read from BloombergApple Is in Talks to Let Google Gemini Power iPhone AI FeaturesTrump Rules Out Vivek Ramaswamy as Running Mate as He Eyes New TeamNvidia Unveils Successor to Its All-Conquering AI ProcessorMusk Says His Ketamine Prescription Is in Investors’ Best InterestsEvergrande’s Alleged $78 Billion
(Bloomberg) -- Pfizer Inc. plans to sell about £2 billion ($2.5 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake. Most Read from BloombergApple Is in Talks to Let Google Gemini Power iPhone AI FeaturesPutin Warns Russia Won’t Stop After Predictable Election WinSaudi Wealth Fund Is in Talks to Acquire National AirlineTop Solar Firm Longi Plans Thousands of Job Cuts on GlutChina’s Growth Bump May Dent Urgency for More
PHILADELPHIA, March 16, 2024--RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer